Prevalence And Microbial Spectrum Of Patients With Spontaneous Bacterial Peritonitis In Northeast Nigeria – A Cross-Sectional Multi-Centre Study
Main Article Content
Keywords
Spontaneous Bacterial peritonitis, Liver cirrhosis, Ascites, Prevalence, Antibiotic sensitivity, Antibiotic resistance
Abstract
Background: Spontaneous bacterial peritonitis (SBP) is the most common infectious complication of cirrhosis, requiring prompt recognition and treatment. It is a recognized cause of death. Normal ascitic fluid is sterile, spontaneous presence of bacteria in this fluid is detrimental and needs to be investigated. This study aimed to determine the prevalence of primary ascitic fluid infection, the microbial agents involved, and their antibiotic sensitivity pattern among patients with cirrhosis and ascites seen at our facilities.
Methodology: A cross-sectional multi-centre study among patients diagnosed with liver cirrhosis and ascites who presented at four major tertiary institutions in Northeastern Nigeria from January 2024 to December 2024. All eligible participants underwent abdominal paracentesis under aseptic conditions and were subjected to microscopy, culture, and sensitivity using the BACT Alert 3D automated method. The data were analysed using SPSS version 26 (IBM SPSS Inc., Chicago, Illinois, USA).
Results: A total of 150 cirrhotic patients were studied, among whom 97 (64.7%) were males, with a male-female ratio of 1.8:1. The age of the patients ranged from 22 to 86 years, with a mean of 53.9 ± 13.4 years. The prevalence of primary ascitic fluid infection was 64%. All the positive culture samples were monomicrobial, and the most commonly isolated organisms were Escherichia coli (43.8%), Staphylococcus aureus (26.0%), and Klebsiella spp. (13.5%). The most sensitive antibiotics were levofloxacin (92 -100%), gentamicin (76.9 – 100%), imipenem (76.9 – 100%), piperacillin-Tazobactam (75.0 – 100%), and ciprofloxacin (69.0 – 100%). Escherichia coli, Klebsiella spp., Pseudomonas aeruginosa, Streptococcus spp., and Enterobacter spp. were found to be 100% resistant to cotrimoxazole. More specifically, Enterobacter spp. was found to be multidrug-resistant (MDR).
Conclusion: The prevalence of primary ascitic fluid infection among the cirrhotic patients was high. It is therefore recommended that prophylactic antibiotics be given to any patient with ascites and cirrhosis to prevent fatal complications of SBP.
References
2. Rostkowska KA, Szymanek-Pasternak A, Simon KA. Spontaneous bacterial peritonitis—therapeutic challenges in the era of increasing drug resistance of bacteria. Clin. Exp. Hepatol. 2018, 4, 224–231, Termedia Publishing House Ltd (Warsaw, Poland).
3. Heo J, Seo YS, Yim HJ, Hahn T, Park SH, Ahn SH, et al. Clinical Features and Prognosis of Spontaneous Bacterial Peritonitis in Korean Patients with Liver Cirrhosis: A Multicenter Retrospective Study. 2009.
4. Ding X, Yu Y, Chen M, Wang C, Kang Y, Lou J. Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: Community-acquired versus nosocomial infections. BMC Infect. Dis. 2019; 19, 463.
5. Dever JB, Sheikh MY. Spontaneous bacterial peritonitis–bacteriology, diagnosis, treatment, risk factors and prevention. Alimentary pharmacology & therapeutics. 2015 Jun;41(11):1116-31.
6. Tay PW, Xiao J, Tan DJ, Ng C, Lye YN, Lim WH, Teo VX, Heng RR, Yeow MW, Lum LH, Tan EX. An epidemiological meta-analysis on the worldwide prevalence, resistance, and outcomes of spontaneous bacterial peritonitis in cirrhosis. Frontiers in Medicine. 2021 Aug 5;8:693652.
7. Gruszecka J, Filip R. Epidemiological Study of Pathogens in Spontaneous Bacterial Peritonitis in 2017-2024-A Preliminary Report of the University Hospital in South-Eastern Poland. Microorganisms. 2024 May 17;12(5):1008. doi: 10.3390/microorganisms12051008.
8. Grover A, Kumar A, Nagpal A, Jindal M, Garg P, Singh PP. Prevalence and Microbiological Profile of Spontaneous Bacterial Peritonitis in Patients of Cirrhosis with Ascites. Int J Acad Med Pharm. 2022;4(5):194-8.
9. Li B, Zhang C, Zhan YT. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis. Can. J. Gastroenterol. Hepatol. 2018; 2018, 2784537.
10. Ekpanyapong S, Reddy KR. Infections in Cirrhosis. Curr. Treat. Options Gastroenterol. 2019, 17, 254–270.
11. Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100. Journal of clinical microbiology. 2021 Nov 18;59(12):10-128
12. Resneck JS. Revisions to the Declaration of Helsinki on its 60th anniversary: a modernized set of ethical principles to promote and ensure respect for participants in a rapidly innovating medical research ecosystem. JAMA. 2025 Jan 7;333(1):15-7.
13. Strauss, E. The impact of bacterial infections on survival of patients with decompensated cirrhosis. Ann. Hepatol. 2014, 13, 7–19.
14. Oey, R.C.; de Man, R.A.; Erler, N.S.; Verbon, A.; van Buuren, H.R. Microbiology and antibiotic susceptibility patterns in spontaneous bacterial peritonitis: A study of two Dutch cohorts ata10-year interval. United Eur. Gastroenterol. J. 2018, 6, 614–621.
15. Almeida, P.R.L.D.; Leão, G.S.; Gonçalves, C.D.G.; Picon, R.V.; Tovo, C.V. Impact of microbiological changes on spontaneous bacterial peritonitis in three different periods over 17 years. Arq. Gastroenterol. 2018, 55, 23–27.
16. Oladimeji AA, Temi AP, Adekunle AE, Taiwo RH, Ayokunle DS. Prevalence of spontaneous bacterial peritonitis in liver cirrhosis with ascites. Pan African Medical Journal. 2013;15(1).
17. Tay PW, Xiao J, Tan DJ, Ng C, Lye YN, Lim WH, Teo VX, Heng RR, Yeow MW, Lum LH, Tan EX. An Epidemiological Meta-Analysis on the Worldwide Prevalence, Resistance, and Outcomes of Spontaneous Bacterial Peritonitis in Cirrhosis. Frontiers in Medicine. 2021 Aug 5;8:693652-.
18. Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. The Lancet infectious diseases. 2010 Jun 1;10(6):417-32.
19. Melariri H, Freercks R, van der Merwe E, Ten Ham-Baloyi W, Oyedele O, Murphy RA, Claasen C, Etusim PE, Achebe MO, Offiah S, Melariri PE. The burden of hospital-acquired infections (HAI) in sub-Saharan Africa: a systematic review and meta-analysis. EClinicalMedicine. 2024 May 1;71.
20. Duah A, Nkrumah KN. Spontaneous bacterial peritonitis among adult patients with ascites attending Korle-Bu Teaching Hospital. Ghana medical journal. 2019 Mar 10;53(1):37-43.
21. Kibrit J, Khan R, Jung BH, Koppe S. Clinical Assessment and Management of Portal Hypertension. Semin Intervent Radiol. 2018;35(3):153-159. doi: 10.1055/s-0038-1660793.
22. Zhang X, Li XX, Song JW, Zhang XC, Zhen C, Bi JF, Lu FY, Chen SM, Dan Huo D, Zhao P, Zhang DW, Tu B, Bao CM, Wang FS, Huang L. Clinical features, microbial spectrum, and antibiotic susceptibility patterns of spontaneous bacterial peritonitis in cirrhotic patients. Dig Liver Dis. 2023 Nov;55(11):1554-1561. doi: 10.1016/j.dld.2023.08.045. Epub 2023 Sep 29.
23. Helil AS, Haile SA, Birhanu Y, Desalegn H, Desalegn DM, Geremew RA, Gebreyohannes Z, Mohammed A, Wondimagegnehu DD, Ayana G, Tizazu AM. Bacterial profile, drug resistance pattern, clinical and laboratory predictors of ascites infection in cirrhosis patients. BMC Infectious Diseases. 2024 May 26;24(1):528.
